Wednesday, February 25, 2026
1:30 PM - 2:30 PM
D. Maria Hall
Joint SFMS , AIUS, SSS, STSC - Session
Moderators:
Carol Burté (France) & Tarek Rouag (France)
1:30 PM - 1:38 PM
Off Label Prescriptions: Why, When and How?
Speaker:
Béatrice Cuzin (France)
1:38 PM - 1:46 PM
Off-Label Use of PDE5 Inhibitors in Women and Men
Speaker:
Charlotte Methorst (France)
1:46 PM - 1:54 PM
Off-Label Ssri Use in Premature Ejaculation: Where Do We Stand?
Speaker:
Sandrine Atallah (Lebanon)
1:54 PM - 2:04 PM
Dopamine-Related Medications in the Field of Sexuel Medecine
Speaker:
Rafael Herrero (France)
2:04 PM - 2:12 PM
How to Feed Own’s Erotism (Through Clinical Cases)
Speaker:
Lakshmi Waber (Switzerland)
2:12 PM - 2:20 PM
Pharmacological Treatment of Compulsive Sexual Behavior Disorder
Speaker:
Lorenzo Soldati (Switzerland)
2:20 PM - 2:30 PM
Q&A
Thursday, February 26, 2026
8:30 AM - 9:30 AM
Archive Hall
Rare Male Sexual Dysfunction
Moderators:
Serkan Deveci (Türkiye), Emmanuele Jannini (Italy) & Mustafa Kadihasanoglu (Türkiye)
8:30 AM - 8:40 AM
Post-Finasteride and SSRI Syndrome
Speaker:
Ioannis Sokolakis (Greece)
8:40 AM - 8:50 AM
Restless Genital Syndrome
Speaker:
Murat Gul (Türkiye)
8:50 AM - 9:00 AM
Post-Orgasmic Illness Syndrome & Delayed Ejaculation
Speaker:
Alan Shindel (USA)
9:00 AM - 9:10 AM
Hard-Flaccid Syndrome
Speaker:
Ege Can Serefoglu (Türkiye)
9:10 AM - 9:30 AM
Q&A
10:30 AM - 12:30 PM
Infante Hall
Abstract Session - Male 1
Moderator:
John Mulhall (USA)
10:30 AM - 10:35 AM
A Multicenter Prospective Study on the Safety and Efficacy of Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Non–Cross-Linked Hyaluronic Acid and Shockwave Preconditioning in the Treatment of Peyronie’s Disease (#026)
Speaker:
Angela Maurizi (Italy)
10:35 AM - 10:40 AM
Sexual Symptoms and Biologic Pathophysiologies of Post-SSRI Sexual Dysfunction: A 15 Year Review (#027)
Speaker:
Sue Goldstein (USA)
10:40 AM - 10:45 AM
Sexual Safety of Rezum Water Vapor Therapy in Patients With Benign Prostatic Hyperplasia: A Single-Center Experience (#028)
Speaker:
Giovanni Antonio Barbieri (Italy)
10:45 AM - 10:50 AM
The Association Between Cancer Treatment and Sexual Health in Danish Cancer Survivors Treated With Curative Intent (#029)
Speaker:
Monika Barsøe (Denmark)
10:50 AM - 10:55 AM
Risk of Climacturia After Laser Enucleation of the Prostate for Benign Prostatic Obstruction (#030)
Speaker:
Ilaria Elena Zais (Italy)
10:55 AM - 11:00 AM
Placebo Effect in Intralesional Injection Therapy for Peyronie’s Disease: A Systematic Review and Meta-Analysis of Published Prospective Clinical Trials (#031)
Speaker:
Sara Baldini (Italy)
11:00 AM - 11:05 AM
Association Between Autoimmune Diseases and Male Reproductive Health: A Mendelian Randomization Study (#032)
Speaker:
Taotao Sun (China)
11:05 AM - 11:10 AM
Evaluation of Pharmacokinetics Profile and Safety Outcomes Comparing Nasal SPONTAN versus Oral Vardenafil Formulations: A Phase 1 Open-Label, Single-Dose, Randomized Cross-Over Clinical Study in Healthy Male Adults (#033)
Speaker:
Eric Chung (Australia)
11:10 AM - 11:15 AM
Identifying Undiagnosed Hypogonadism: The Role of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Screening (#034)
Speaker:
Chia-Chu Liu (Taiwan)
11:15 AM - 11:20 AM
FAST REGEN: A Prospective Single-Center Feasibility and Safety Study of a Single-Session High-Dose Shockwave Protocol (18 000 Pulses) Followed by Platelet-Rich Plasma (PRP) Injection for Erectile Dysfunction (#035)
Speaker:
Angela Maurizi (Italy)
11:20 AM - 11:25 AM
Predictors of Treatment Regret After Laser Enucleation of the Prostate for Benign Prostatic Obstruction (#036)
Speaker:
Ilaria Elena Zais (Italy)
11:25 AM - 11:30 AM
Lipid Accumulation Product and Body Composition Indices as Predictors of Erectile Dysfunction: Correlation-Based Insights into Metabolic Risk (#037)
Speaker:
Ali şahin (Türkiye)
11:30 AM - 11:35 AM
Impact of Primary Treatment for Testicular Tumours on Hormonal Profile and Spermatogenesis: Results From a Single-Tertiary Referral Centre (#038)
Speaker:
Maurizio De Rocco Ponce (Spain)
11:35 AM - 11:40 AM
A Game-Changer: Allograft-Assisted Cavernous Nerve Reconstruction During Radical Prostatectomy (#039)
Speaker:
Tung Shu (USA)
11:40 AM - 11:45 AM
Can Glucagon-Like Peptide-1 Receptor Agonists Be Used in Men With Type 2 Diabetes Mellitus or Obesity Who Complain of Erectile Dysfunction? A Systematic Review and Meta-Analysis (#040)
Speaker:
Joao Pedro Campos Lima (Brazil)
11:45 AM - 11:50 AM
Characteristics of Secondary Hypogonadism Defined by LH Levels but With Elevated FSH: Results From a Cohort of Men Seeking Specialist Evaluation for Sexual Dysfunction (#041)
Speaker:
Alessio Bombardieri (Italy)
11:50 AM - 11:55 AM
Neuromodulation-Sphincter Control Training (SCT-Plus) Protocol for Primary Premature Ejaculation: A 7-Session Pilot Case Series (#042)
Speaker:
Jesús Eugenio Rodríguez Martínez (Spain)
11:55 AM - 12:00 PM
Intraplaque Injections of Perovial for the Treatment of Peyronie’s Disease: A Retrospective Single-Center Experience (#043)
Speaker:
Assunta Zimarra (Italy)
12:00 PM - 12:05 PM
Assessment of Ejaculation Status and Ejaculation Sparing Techniques in Laser Enucleation of the Prostate: A Systematic Review (#044)
Speaker:
Mehmet Yilmaz (Germany)
12:05 PM - 12:10 PM
Very Long Term Outcomes After Testicular Fixation for Intermittent Testicular Torsion in Adults (#045)
Speaker:
Alessio Villano (Italy)
12:10 PM - 12:15 PM
Twelve-Week Outcomes and Complication Rates Following Penile Prosthesis Surgery: Results From the EAU Research Foundation PHOENIX Registry (#891)
Speaker:
Helene De Bruyn (Belgium)
12:15 PM - 12:20 PM
Predictors of Penile Prosthesis Length: Results from the PHOENIX Registry (#892)
Speaker:
Alvaro Yebes (Spain)
Saturday, February 28, 2026
8:30 AM - 9:30 AM
Abstract Session - Basic Science 1
8:30 AM - 8:35 AM
Functional Vascular Architecture of the Human Clitoris (#165)
Speaker:
Maeva Badré (Switzerland)
8:35 AM - 8:40 AM
Paroxetine-Induced Alterations in Neurosteroidogenic Gene Expression in the Female Nucleus Accumbens: Insights Into Post-SSRI Sexual Dysfunction (#166)
Speaker:
Gabriela Chrostek (Italy)
8:40 AM - 8:45 AM
IP2018, a Dual Serotonin and Dopamine Reuptake Inhibitor, Promotes Spontaneous Erections in a New Depressive-Erectile Dysfunctional Animal Model (#167)
Speaker:
Simon Gabriel Comerma Steffensen (Denmark)
8:45 AM - 8:50 AM
Mechanisms by Which Silencing of Fidgetin-like 2 (FL2) During Cavernous Nerve Injury Accelerates Nerve Regeneration and Recovery of Erectile Function (#168)
Speaker:
Kelvin Davies (USA)
8:50 AM - 8:55 AM
Neural Correlates of Female Sexual Response: An EEG Study (#169)
Speaker:
Celeste Bittoni (Italy)
8:55 AM - 9:00 AM
Effects of Oral Vitamin D Supplementation in an Experimental Model of Peyronie’s Disease (#170)
Speaker:
Leonardo Seligra Lopes (Brazil)
9:00 AM - 9:05 AM
Catheter Associated Urinary Tract Infections, Distal Urethra Bacteria Presence, Hope of Reducing IPP Infections: Comparison of 2 Catheters, 3 Solutions, and 3 Organisms With E. Coli Bacterial Load Reduction (#171)
Speaker:
Spencer Pringle (USA)
9:05 AM - 9:10 AM
Spinal Contusion Injury-Induced Ejaculatory Dysfunction Is Reduced by Intrathecal Infusions of Gastrin Releasing Peptide in Male Rats (#172)
Speaker:
Yu Seob Shin (South Korea)
9:10 AM - 9:15 AM
Effects of Rotating Magnetic Field on Diabetic Corpus Cavernosum Injury in Rats: Modulation of Inflammation and the TGF-β/Smad Signaling Pathway (#173)
Speaker:
Luo Yang (China)
9:15 AM - 9:20 AM
Cadaveric Anatomical Description of the Penile Suspensory Apparatus (#174)
Speaker:
Pawarit Wipaswatcharayotin (Thailand)
9:20 AM - 9:25 AM
Exploring the Downstream Effects of Regulation of Genes of Interest in Peyronie’s Disease (#175)
Speaker:
Michael Christensen (USA)